Cite
HARVARD Citation
Weekes, C. et al. (2019). A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors. International journal of cancer. 145 (9), pp. 2450-2458. [Online].